Skip to main content
Top
Published in: Annals of Behavioral Medicine 2/2015

01-04-2015 | Invited Commentary

Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub

Author: Kristen Underhill, D. Phil., J. D.

Published in: Annals of Behavioral Medicine | Issue 2/2015

Login to get access

Excerpt

As evidence grows for the effectiveness of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention [16], complementary research on PrEP acceptability [7] and uptake [813] has gained prominence. In the USA, PrEP acceptability research has largely focused on men who have sex with men (MSM) [14], given the sustained burden of HIV incidence in this group [15]. Although this work has identified many individual factors associated with willingness to use PrEP, emerging research has also examined PrEP acceptability in light of MSM partnership dynamics [1619]. Focusing on dyads is imperative: at least one third of HIV infections among US MSM occur within primary partnerships [20, 21], and relationship dynamics—including intimacy, commitment, and other interpersonal factors—demonstrably influence both HIV risk and protective behaviors [22, 23]. For example, prior studies report that many MSM in primary partnerships engage in condomless sex to express intimacy, and condom nonuse may be motivated by the desire to preserve these intimacy benefits [2427]. …
Literature
1.
2.
3.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.CrossRefPubMed Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.CrossRefPubMed
4.
go back to reference Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083-2090.CrossRefPubMed Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083-2090.CrossRefPubMed
5.
go back to reference Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012, 4:151ra125. Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012, 4:151ra125.
6.
go back to reference Donnell D, Baeten JM, Bumpus NN, et al. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. J Acquir Immune Defic Syndr. 2014. Donnell D, Baeten JM, Bumpus NN, et al. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. J Acquir Immune Defic Syndr. 2014.
7.
go back to reference Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195-216.CrossRefPubMedCentralPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195-216.CrossRefPubMedCentralPubMed
8.
go back to reference Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11:e1001613.CrossRefPubMedCentralPubMed Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11:e1001613.CrossRefPubMedCentralPubMed
9.
go back to reference Bush S, Rawlings K, Ng L, Mera R. Regional differences in the utilization of Truvada for PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 353. Bush S, Rawlings K, Ng L, Mera R. Regional differences in the utilization of Truvada for PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 353.
10.
go back to reference Mera R, Rawlings K, Pechonkina A, et al. Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO, 2013, Abstract H-663a. Mera R, Rawlings K, Pechonkina A, et al. Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO, 2013, Abstract H-663a.
11.
go back to reference Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014.
12.
go back to reference Ndase P, Celum C, Campbell J, et al. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Partners PrEP study experience. J Acquir Immune Defic Syndr. 2014;66:206-212.PubMed Ndase P, Celum C, Campbell J, et al. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Partners PrEP study experience. J Acquir Immune Defic Syndr. 2014;66:206-212.PubMed
13.
go back to reference King HL, Keller SB, Giancola MA, et al. Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study). AIDS Behav. 2014;18:1722-1725.CrossRefPubMed King HL, Keller SB, Giancola MA, et al. Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study). AIDS Behav. 2014;18:1722-1725.CrossRefPubMed
14.
go back to reference Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166-170.PubMed Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166-170.PubMed
15.
go back to reference CDC: HIV among gay and bisexual men. Atlanta, GA: U.S. Dept of Health and Human Services, 2014. CDC: HIV among gay and bisexual men. Atlanta, GA: U.S. Dept of Health and Human Services, 2014.
16.
go back to reference Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43:99-106.CrossRefPubMed Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43:99-106.CrossRefPubMed
17.
go back to reference Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7:e50061.CrossRefPubMedCentralPubMed Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7:e50061.CrossRefPubMedCentralPubMed
18.
go back to reference Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.CrossRefPubMedCentralPubMed Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.CrossRefPubMedCentralPubMed
19.
go back to reference Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26:87-94.CrossRefPubMedCentralPubMed Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26:87-94.CrossRefPubMedCentralPubMed
20.
go back to reference Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.CrossRefPubMedCentralPubMed Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.CrossRefPubMedCentralPubMed
21.
go back to reference Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.CrossRefPubMed Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.CrossRefPubMed
22.
go back to reference Burton J, Darbes L, Operario D. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of the evidence. AIDS Behav. 2010;14:1-10.CrossRefPubMedCentralPubMed Burton J, Darbes L, Operario D. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of the evidence. AIDS Behav. 2010;14:1-10.CrossRefPubMedCentralPubMed
24.
go back to reference Hoff CC, Chakravarty D, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738-745.CrossRefPubMedCentralPubMed Hoff CC, Chakravarty D, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738-745.CrossRefPubMedCentralPubMed
25.
go back to reference Darbes LA, Chakravarty D, Neilands TB, Beougher SC, Hoff CC. Sexual risk for HIV among gay male couples: a longitudinal study of the impact of relationship dynamics. Arch Sex Behav. 2014;43:47-60.CrossRefPubMed Darbes LA, Chakravarty D, Neilands TB, Beougher SC, Hoff CC. Sexual risk for HIV among gay male couples: a longitudinal study of the impact of relationship dynamics. Arch Sex Behav. 2014;43:47-60.CrossRefPubMed
26.
go back to reference Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014;43:73-87.CrossRefPubMedCentralPubMed Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014;43:73-87.CrossRefPubMedCentralPubMed
27.
go back to reference Golub SA, Starks TJ, Payton G, Parsons JT. The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. AIDS Behav. 2012;16:626-632.CrossRefPubMedCentralPubMed Golub SA, Starks TJ, Payton G, Parsons JT. The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. AIDS Behav. 2012;16:626-632.CrossRefPubMedCentralPubMed
28.
go back to reference Gamarel KE, Golub SA: Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships. Ann Behav Med. 2014. doi:10.1007/s12160-014-9646-3. Gamarel KE, Golub SA: Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships. Ann Behav Med. 2014. doi:10.​1007/​s12160-014-9646-3.
29.
go back to reference Gilmore H, Koester K, Liu A, et al. To take or not to take PrEP: Perspectives from participants enrolled in the iPrEx Open Label Extension (OLE) in the United States. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 440. Gilmore H, Koester K, Liu A, et al. To take or not to take PrEP: Perspectives from participants enrolled in the iPrEx Open Label Extension (OLE) in the United States. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 440.
30.
go back to reference Koester K, Amico KR, Liu A, et al. Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. XX International AIDS Conference. Melbourne, Australia, 2014, Abstract TUAC0102. Koester K, Amico KR, Liu A, et al. Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. XX International AIDS Conference. Melbourne, Australia, 2014, Abstract TUAC0102.
31.
go back to reference Patel V, Estabrook S, Smith K, Golub S, et al. Motivators and concerns for adopting pre-exposure prophylaxis in men who have sex with men using mobile dating "apps" in New York City. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 434. Patel V, Estabrook S, Smith K, Golub S, et al. Motivators and concerns for adopting pre-exposure prophylaxis in men who have sex with men using mobile dating "apps" in New York City. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 434.
32.
go back to reference Underhill K, Morrow K, Operario D, et al. Project PrEP Talk: An in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, D.C., USA, 2012, Abstract TUPD0306. Underhill K, Morrow K, Operario D, et al. Project PrEP Talk: An in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, D.C., USA, 2012, Abstract TUPD0306.
33.
go back to reference Corneli A, Perry B, Kawango Agot, et al. Participant Explanations for Study Product Adherence in FEM-PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 366. Corneli A, Perry B, Kawango Agot, et al. Participant Explanations for Study Product Adherence in FEM-PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 366.
34.
go back to reference Jiwatram-Negron T, El-Bassel N: Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions. AIDS Behav. 2014. Jiwatram-Negron T, El-Bassel N: Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions. AIDS Behav. 2014.
35.
go back to reference Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.CrossRefPubMed Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.CrossRefPubMed
36.
go back to reference Wu E, El-Bassel N, McVinney LD, et al. Feasibility and promise of a couple-based HIV/STI preventive intervention for methamphetamine-using, black men who have sex with men. AIDS Behav. 2011;15:1745-1754.CrossRefPubMed Wu E, El-Bassel N, McVinney LD, et al. Feasibility and promise of a couple-based HIV/STI preventive intervention for methamphetamine-using, black men who have sex with men. AIDS Behav. 2011;15:1745-1754.CrossRefPubMed
37.
go back to reference Stephenson R, Sullivan PS, Salazar LF, et al. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80-S87.CrossRefPubMedCentralPubMed Stephenson R, Sullivan PS, Salazar LF, et al. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80-S87.CrossRefPubMedCentralPubMed
38.
go back to reference CDC: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2014: A Clinical Practice Guideline, 2014. CDC: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2014: A Clinical Practice Guideline, 2014.
Metadata
Title
Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub
Author
Kristen Underhill, D. Phil., J. D.
Publication date
01-04-2015
Publisher
Springer US
Published in
Annals of Behavioral Medicine / Issue 2/2015
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-014-9651-6

Other articles of this Issue 2/2015

Annals of Behavioral Medicine 2/2015 Go to the issue